Improvement in progression-free survival in OCEANS bevacizumab arm: a critical point of view
- PMID: 23169499
- DOI: 10.1200/JCO.2012.44.6237
Improvement in progression-free survival in OCEANS bevacizumab arm: a critical point of view
Comment on
-
OCEANS: a randomized, double-blind, placebo-controlled phase III trial of chemotherapy with or without bevacizumab in patients with platinum-sensitive recurrent epithelial ovarian, primary peritoneal, or fallopian tube cancer.J Clin Oncol. 2012 Jun 10;30(17):2039-45. doi: 10.1200/JCO.2012.42.0505. Epub 2012 Apr 23. J Clin Oncol. 2012. PMID: 22529265 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical